BridgeMD
Compares treatment options for Intraoperative Fluoroscopy
Official title Total Hip Arthroplasty: Fluoroscopy vs Freehand
ClinicalTrials.gov ID: NCT05653687
What this study is testing
- What it's testing
- The aim of the study is to compare total hip arthroplasty intervention executed with or without the use of intraoperative fluoroscopy in terms of positioning of the hip prosthesis. The comparison will be made on post-operative follow-up X-ray performed as per clinical practice, in order to verify if intraoperative fluoroscopy provides better prosthesis components positioning or not.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Patients undergoing unilateral primary THA through DAA
- Patients aged 18-90 years old.
- Patients with a BMI \>18 and \<35.
- Patients able to provide informed consent.
- Informed consent as documented by signature.
You likely can't join if
- Revision THA.
- Women who are pregnant or breast feeding.
- Presence of other clinically significant concomitant disease states (ASA IV).
- Previous enrolment into the current study.
- Enrolment of the investigator, his/her family members, employees and other dependent persons.
The study team makes the final eligibility decision.
Where it's taking place
- Lugano, Canton Ticino, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lugano, Canton Ticino, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.